Dynamic and Static Effects of the Systemic Inflammatory Response Index on All‐Cause Mortality in Individuals With Atherosclerotic Cardiovascular Disease: Evidence From National Health and Nutrition Examination Survey
Mediators of Inflammation · 2025
DOI: 10.1155/mi/5343213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, 2025. Verfasst von Chenglin Duan und 5 weiteren Autor:innen. Beteiligte Einrichtung: China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing 100053, China. Hauptthemen laut MEDLINE: Atherosclerosis, Inflammation, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Capital Health Research and Development of Special Fund.
Abstract (Originalsprache)
Objective
This research focuses on analyzing the link between the systemic inflammatory response index (SIRI) and all‐cause mortality in individuals with atherosclerotic cardiovascular disease (ASCVD) .
Methods
This research analyzed data from 4693 patients using nine cycles of the National Health and Nutrition Examination Survey (NHANES). The connection between SIRI and mortality was determined by employing survey‐weighted Cox models, with hazard ratios (HRs) and 95% confidence intervals (CIs) being computed. Kaplan–Meier method illustrated survival differences across SIRI levels. Sensitivity analyses involved restricted cubic splines (RCS), stratified analysis, and E ‐value calculations. Landmark analysis assessed survival differences at multiple follow‐up intervals, while time‐dependent receiver operating characteristic curves evaluated SIRI’s prognostic value. Mediation analysis identified potential intermediaries impacting the SIRI–mortality relationship.
Results
Over 406,564 person–months, 1933 deaths occurred. Adjusted Cox models discovered that higher SIRI was connected with elevated overall mortality [HR 1.192, (95% CI 1.131–1.256), p < 0.001]. Higher SIRI consistently showed lower survival probabilities. RCS and stratified analysis confirmed the robustness of these findings. Survival probability at different follow‐up periods was considerably lower in those with higher SIRI. Additionally, SIRI demonstrated a prognostic value of 0.66 for all‐cause mortality at 1 year and 3 years, and 0.65 at 5 years. Notably, serum uric acid (6.2%) partially mediated the connection between SIRI and mortality from all causes.
Conclusion
In ASCVD patients, SIRI was robustly correlated with all‐cause mortality, partially mediated by serum uric acid.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing 100053, China.
- Graduate School of Beijing University of Chinese Medicine, Beijing 100029, China.
ORCID-Profile: Chenglin Duan, Yuanhui Hu
Förderung
- Capital Health Research and Development of Special Fund
Zitieren
APA
Duan, C., Du, Y., Chen, J., Shi, S., Zhang, X., & Hu, Y. (2025). Dynamic and Static Effects of the Systemic Inflammatory Response Index on All‐Cause Mortality in Individuals With Atherosclerotic Cardiovascular Disease: Evidence From National Health and Nutrition Examination Survey. Mediators of Inflammation. https://doi.org/10.1155/mi/5343213
Vancouver
Duan C, Du Y, Chen J, Shi S, Zhang X, Hu Y. Dynamic and Static Effects of the Systemic Inflammatory Response Index on All‐Cause Mortality in Individuals With Atherosclerotic Cardiovascular Disease: Evidence From National Health and Nutrition Examination Survey. Mediators of Inflammation. 2025. doi:10.1155/mi/5343213
BibTeX
@article{Duan2025,
author = {Duan, Chenglin and Du, Yihang and Chen, Jiafan and Shi, Shuqing and Zhang, Xiaohan and Hu, Yuanhui},
title = {Dynamic and Static Effects of the Systemic Inflammatory Response Index on All‐Cause Mortality in Individuals With Atherosclerotic Cardiovascular Disease: Evidence From National Health and Nutrition Examination Survey},
journal = {Mediators of Inflammation},
year = {2025},
doi = {10.1155/mi/5343213}
}
EUVIMED